Core Viewpoint - Robbins LLP has announced a class action lawsuit against Trip.com Group Limited, alleging that the company understated regulatory risks associated with its monopolistic business practices, which led to misleading statements about its operations and prospects [1][1][1] Allegations - The lawsuit claims that during the class period from April 30, 2025, to January 13, 2026, Trip.com failed to disclose significant regulatory risks due to its monopolistic activities [1][1] - On January 14, 2026, Bloomberg reported that China was investigating Trip.com for alleged antitrust conduct, which resulted in a significant drop in the company's American Depository Shares (ADS) price by $12.90, or 17.05%, closing at $62.78 [1][1] - The following day, the ADS price fell further by $1.48, or 2.35%, to close at $61.30 [1][1] Company Background - Trip.com Group Limited is positioned as a leading global one-stop travel service provider, offering a comprehensive suite of travel products and services [1][1][1]

Core Viewpoint - A class action lawsuit has been filed against Trip.com Group Limited for securities purchased between April 30, 2024, and January 13, 2026, seeking to recover damages under federal securities laws [1] Group 1 - The lawsuit is initiated by Rosen Law Firm, which specializes in investor rights [1] - The class action aims to represent investors who purchased Trip.com securities during the specified class period [1] - Investors interested in joining the class action can find more information on the Rosen Law Firm's website or contact a representative [1]

Core Viewpoint - The article discusses the increasing demand for English-speaking customer service positions at Ctrip, highlighting how these roles have become attractive to recent graduates, particularly those with overseas study experience, due to competitive salaries and perceived job stability [4][6][25]. Group 1: Job Market Dynamics - Ctrip's English customer service positions are seen as a "refuge" for international students, with high competition for roles requiring strong English skills and educational backgrounds [4][6]. - The salary for Ctrip's English online customer service ranges from 11,000 to 14,000 yuan, which is higher than some entry-level positions in other tech companies [7][8]. - Many graduates prioritize salary over job satisfaction, with some choosing Ctrip over firms like PwC due to better pay [8][11]. Group 2: Work Environment and Responsibilities - The role offers a work-life balance, but employees often face pressure from KPIs and may end up working overtime voluntarily [10][11]. - Ctrip's customer service positions are distinct from traditional roles, focusing on international clients and requiring higher language proficiency, which is reflected in the job's appeal to graduates [17][18]. - The work involves handling customer complaints, managing hotel partnerships, and addressing complex issues, often requiring significant mental effort [21][22]. Group 3: Career Progression and Perception - Many view customer service roles as a stepping stone to other positions within Ctrip, although opportunities for internal transfers have become limited [26][27]. - Ctrip's customer service team is substantial, with over 16,000 employees, making it a critical part of the company's operations [27][29]. - The company emphasizes the importance of customer service in maintaining high profit margins and customer satisfaction, which has been a key factor in its success [30][31]. Group 4: Future of Customer Service - Despite advancements in AI, the demand for human customer service representatives remains strong due to the complexity of customer interactions [31][32]. - Ctrip has implemented measures to support its customer service staff, recognizing the high stress associated with the role, especially during peak seasons [32][33].

Investment Rating - The report maintains an "Overweight" rating for the overseas pharmaceutical industry, indicating a positive outlook for the sector's performance compared to the overall market [5][10]. Core Insights - The report highlights significant developments in the pharmaceutical sector, including a licensing agreement between China National Pharmaceutical Group (Sinopharm) and Sanofi for the JAK/ROCK inhibitor, and the approval of a new indication for Innovent Biologics' BTK inhibitor in China [1][2]. - Performance forecasts for companies such as Crystal Holding and He Yu indicate substantial revenue growth, with Crystal Holding expected to achieve at least 780 million RMB in revenue for 2025, representing a year-on-year increase of approximately 193% [6][7]. Summary by Sections 1. Overseas Pharmaceuticals - Sinopharm and Sanofi have entered into an exclusive licensing agreement for the global development, production, and commercialization of the JAK/ROCK inhibitor, with potential milestone payments totaling up to 1.395 billion USD [2][7]. - Innovent Biologics' BTK inhibitor, Jiepalit (Pirtobrutinib), has received NMPA approval for a new indication in adult patients with chronic lymphocytic leukemia (CLL) who have previously undergone systemic treatment [2][7]. - Roche's BTK inhibitor Fenebrutinib has successfully met primary endpoints in a Phase III trial for relapsing multiple sclerosis, potentially becoming the first effective oral treatment for both relapsing and primary progressive forms of the disease [3][8]. 2. Performance Updates - Crystal Holding anticipates a revenue of no less than 780 million RMB in 2025, with a net profit of at least 100 million RMB, marking a turnaround from losses [6][7]. - He Yu expects to achieve 612 million RMB in revenue for 2025, reflecting a 21% year-on-year growth, with net profit projected at 55 million RMB, a 95% increase [6][7]. 3. Investment Recommendations - The report suggests focusing on innovative pharmaceutical companies with active commercialization and business development opportunities, including companies like BeiGene, Innovent Biologics, and others [10]. - It also highlights the importance of monitoring clinical progress in key pipelines for companies transitioning towards innovation [10].

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into possible securities fraud involving Trip.com Group Limited and may file a class action on behalf of investors [1]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm is encouraging investors to contact them to discuss their legal rights and options for pursuing claims to recover losses [2]. - The firm has a history of representing investors in claims related to corporate wrongdoing, having recovered over $5.5 billion for aggrieved investors [4]. Group 2: Stock Performance and Market Reaction - Trip.com's stock price experienced a significant decline, falling as much as 18% during intraday trading on January 14, 2026, following the announcement of an investigation related to China's Anti-Monopoly Law [3].

Group 1 - The Hang Seng Index opened up by 0.15% [1] - The Hang Seng Tech Index increased by 0.47% [1] - JD Logistics rose by over 6% [1] - JD Health and Trip.com Group both increased by over 3% [1] - NetEase, JD Group, and Xiaomi Group showed significant gains [1]

Market Overview - A-shares and Hong Kong stocks showed a collective strength today, with A-shares opening lower but rising throughout the morning session [1][2] - The Shanghai Composite Index rose by 0.25%, the Shenzhen Component increased by 0.8%, the ChiNext Index gained 0.85%, and the Sci-Tech Innovation Index climbed 1.29% [4] Sector Performance - The pharmaceutical and biotechnology sector experienced a significant surge, with the sector rising over 2% and multiple stocks hitting the daily limit [5] - The agricultural sector also performed well, with gains exceeding 3%, highlighted by stocks like Xiangjia Co. and Dunhuang Seed Industry reaching their daily limits [5] - Other sectors such as environmental protection, basic chemicals, construction decoration, social services, and military industry also saw notable increases [7] Notable Stocks - Key stocks in the pharmaceutical sector included: - Yahui Pharmaceutical-U (688176) with a price of 16.78, up 20.03% [6] - Huakang Clean (301235) at 56.43, up 11.94% [6] - International Medicine (000516) at 5.01, up 10.11% [6] - The virtual power plant concept stocks performed strongly, with the index surging over 3% and several stocks hitting their daily limits [9] New Listings - The newly listed stock, Gude Electric Materials, saw its price increase by over 150% during trading. The company specializes in thermal runaway protection components for electric vehicle batteries and high-performance insulation products for electrical applications [12] Hong Kong Market - The Hong Kong market also showed positive momentum, with the Hang Seng Index rising nearly 2% and the Hang Seng Technology Index increasing by over 3% [14] - Major stocks in the Hang Seng Technology Index, such as JD.com, Trip.com, and NetEase, saw price increases exceeding 5% [16]

Macro Strategy - The government work report aligns with market expectations on total policy but emphasizes details in investment, consumption, green initiatives, fiscal policy, and livelihood, indicating a strategic layout from subtle details [1][9] - A policy financial tool of 800 billion, an increase of 300 billion from last year, aims to explore investment potential [1][9] - A special fund of 100 billion for fiscal-financial collaboration is established to promote consumption and expand domestic demand [1][9] - The energy consumption target is replaced with a carbon emission target, aiming for a 3.8% reduction in carbon emissions per unit of GDP [1][9] - Housing security for newly married and childbearing families is strengthened, encouraging marriage and childbirth while aiding real estate inventory reduction and cost reduction [1][9] Fixed Income - Xianghe Convertible Bond (113701) has a total issuance scale of 400 million, with net proceeds allocated for smart equipment production and a new plastic modification material production line [2][12] - Tonglian Convertible Bond (118066) has a total issuance scale of 576 million, with net proceeds directed towards a new smart home appliance manufacturing base [3][14] - The expected listing price for Xianghe Convertible Bond is between 125.96 and 139.97, with a subscription rate of 0.0015% [12] - The expected listing price for Tonglian Convertible Bond is between 139.70 and 155.09, with a subscription rate of 0.0023% [14] Industry Insights - Ctrip Group's international business continues to grow rapidly, with a focus on inbound tourism strategies [7][8] - The forecast for Ctrip's non-GAAP net profit for 2026-2028 is 20 billion, 22 billion, and 23.9 billion respectively, with corresponding PE ratios of 12, 11, and 10 times [8]

Macro and Strategy - The 2026 government work report emphasizes the priority of "high-quality development" over "stability" with a GDP growth target adjusted to 4.5%-5.0%, aiming to balance growth and quality during a transitional period [7][8] - Fiscal policy remains "more proactive," with a total broad deficit of 11.89 trillion yuan and a deficit rate of approximately 8.1%, reflecting a slight decrease from the previous year [8] - Monetary policy is expected to remain "moderately loose," with anticipated adjustments including one rate cut and one reserve requirement ratio reduction in 2026 [8] Petrochemical Industry - The petrochemical industry investment strategy for March 2026 recommends focusing on rising crude oil and natural gas prices driven by geopolitical factors, particularly following military actions in the Middle East that disrupted energy supplies [9][10] - The conflict has led to significant price increases in European natural gas, with prices surging over 50% due to supply disruptions from Iran and Qatar [9] - The supply side is experiencing a downturn in fixed asset investment, indicating the end of the expansion cycle, while policies are aimed at eliminating low-priced, disordered competition [10] - Demand is expected to recover moderately due to global central banks entering a rate-cutting cycle, alongside growth in new energy and AI sectors driving demand for key chemicals [11] - The report forecasts Brent crude oil prices stabilizing between $70-$75 per barrel and WTI prices between $65-$70 per barrel in 2026, with specific investment recommendations for companies like China National Offshore Oil Corporation and China Petroleum [12] Retail Industry - The retail investment strategy for March 2026 highlights the proactive positioning of leading beauty brands for the upcoming International Women's Day promotions, with expectations for improved performance due to new product launches [17] - Gold prices have seen significant fluctuations, with a year-to-date increase of 22.34%, impacting consumer sentiment and sales in the jewelry sector [18] - The report maintains an "outperform" rating for the retail sector, suggesting that leading companies in gold and beauty will continue to grow despite short-term market volatility [19] Ctrip Group - Ctrip's Q4 2025 revenue grew by 20.8% year-on-year, outperforming expectations, with a total revenue of 15.4 billion yuan [20][21] - The company is focusing on enhancing user experience and optimizing traffic monetization, with significant growth in overseas bookings through its Trip.com platform [21] - Regulatory scrutiny regarding antitrust issues is a key concern, but the company's strong operational capabilities and supply chain integration are expected to support steady growth [22][23]

Investment Rating - The report does not explicitly provide an investment rating for the wealth management industry or specific funds [1][6][11]. Core Insights - The report highlights the performance of major stock indices, with the S&P 500 index at 6878.88, showing a weekly decline of 0.44% and a year-to-date increase of 0.49% [13]. - The report notes that the Invesco Global High-Quality Corporate Bond Fund has an average credit rating of A- and a duration of 6.0 years, indicating a moderate risk profile [19]. - The escalation of the US-Iran conflict has led to increased risk aversion in global markets, with funds flowing into traditional safe-haven assets like gold and US Treasuries [19]. - The report emphasizes that high-rated US Treasuries are seen as a core choice for risk-averse investors due to their low-risk attributes and liquidity [19]. - The fund's performance over the past year was 6.18%, slightly below the Bloomberg US Corporate Bond Index's 6.91% return, attributed to conservative credit selection [22]. Summary by Sections Market Performance - Major stock indices have shown varied performance, with the Nasdaq index down 0.95% year-to-date and the Dow Jones index up 1.90% [13]. - The report provides a detailed table of bond indices, with the Bloomberg US Treasury Index showing a year-to-date increase of 1.72% [26]. Fund Highlights - The Invesco Global High-Quality Corporate Bond Fund has 747 investments, ensuring diversification and reducing credit risk [19][24]. - The fund's geographic distribution includes the US (27.7%), UK (14%), and Italy (5.8%), with no single country exceeding 30% to mitigate economic and policy risks [24]. Recent Market Developments - The report discusses the recent issuance in the primary market, with New City Development issuing a 3-year bond of $355 million at a yield of 13.25% [36]. - It also mentions the positive outlook for Hong Kong property prices, with Morgan Stanley raising its forecast from 5%-7% to 10%-15% for the year [41].